Teva gets approval to buy Bentley

Teva Pharmaceutical Industries received nearly a 69 percent shareholder approval to complete its $360 million dollar purchase of Bentley Pharmaceuticals, a move the company hopes will help it to expand sales in Spain with over 170 products. Report.

Suggested Articles

More than a year after J&J and Bayer pulled the plug on Xarelto in patients after a rare valve replacement, the pair are still seeking answers.

Novartis hopes to leverage its existing presence in the hematology community to achieve a successful launch of Adakveo.

AstraZeneca's Farxiga is touting its heart failure data in patients with or without diabetes, but results in non-diabetics looks particularly strong.